His Approach to Care
Discover Mr Khoubehi's personalised approach to patient care, commitment to clinical excellence, and specialist expertise.
About Mr Khoubehi
Mr Bijan Khoubehi is a highly experienced Consultant Urological Surgeon with a distinguished career spanning more than two decades. He holds a senior NHS appointment at Chelsea and Westminster Hospital NHS Foundation Trust, where he serves as Lead Clinician and MDT Lead for the urology department.
Recognised as a pioneer in robotic urological surgery, Mr Khoubehi has been performing robotic radical prostatectomies since 2007, making him one of the earliest adopters of this advanced technique in the United Kingdom. As a high-volume robotic surgeon, his published outcomes for cancer control, continence recovery and preservation of sexual function are comparable to the finest results reported internationally.
His expertise and reputation have earned recognition in Tatler's prestigious doctors' guide, and his work has been featured in national media including i News, the Daily Mail and Mirror.
Based in London, Mr Khoubehi is dedicated to delivering exceptional, patient-centred urological care.
Training & Education
MB BS with Honours in Surgery
Charing Cross and Westminster Medical School (now part of Imperial College London)
FRCS (Urology)
Fellowship of the Royal College of Surgeons
MD (Doctor of Medicine)
University of London — research degree focusing on developmental genes in prostate cancer
Urological Oncology Fellowships
Completed comprehensive general urological training across London, followed by two dedicated fellowship years in urological oncology
Robotic Surgery Pioneer
Awarded a British Urological Foundation scholarship to train in robotic surgery. Began performing robotic radical prostatectomies in 2007 — among the first UK surgeons to adopt and master this technique
Research & Publications
Mr Khoubehi has made significant contributions to urological science, with a particular emphasis on the molecular mechanisms underlying prostate cancer. His landmark research investigated the role of PAX2, a developmental gene, in prostate carcinogenesis — work that has advanced the understanding of how embryonic pathways become reactivated in malignancy.
His commitment to advancing surgical knowledge is reflected in a substantial body of published research, ensuring that his clinical practice remains grounded in the latest evidence and innovation.
Selected Publications
IP8-FLUORESCE: a prospective paired cohort study evaluating the diagnostic accuracy of fluorescence confocal microscopy for real-time assessment of surgical margins in radical prostatectomy
Mayor N, Light A, Silvanto A, Haider A, Cullen E, Ng C, Boaz RJ, Gopalakrishnan A, Khoubehi B, Hellawell G, Almeida-Magana R, Mendes L, Dinneen E, Shaw G, Challacombe B, Cathcart P, Connor MJ, Shah TT, Ahmed HU, Fiorentino F, Winkler M.
Eur Urol · 2026; 89(3): 223–232
Deep learning for fluorescence confocal microscopy image interpretation in radical prostatectomy
Fang L, Mayor N, Light A, Silvanto A, Haider A, Ng C, Gopalakrishnan A, Boaz RJ, Bertoncelli Tanaka M, Khoubehi B, Hellawell G, Almeida-Magana R, Mendes L, Dinneen E, Shaw G, Challacombe B, Cathcart P, Connor MJ, Shah TT, Ahmed HU, Fiorentino F, Giannarou S, Winkler M.
BJU Int · 2026; 138(S1)
Combination cytoreductive surgery, radiotherapy, or ablation for de novo metastatic prostate cancer: the IP2-ATLANTA internal pilot, phase 2, randomised controlled trial
Connor MJ, Shah TT, Sukumar J, Basak D, Fiorentino F, Heath C, Horan G, Johnson N, Khoo V, Khoubehi B, Klimowska-Nassar N, Mangar S, McGrath J, Nohpal de la Rosa C, Price D, Rai B, Sarwar N, Smith A, Staffurth JN, Tam H, Thippu Jayaprakash K, Winkler M, Dudderidge T, Ahmed HU, et al.
Eur Urol Oncol · 2026; 9(2): 276–285
Does obesity lead to higher positive surgical margins in patients undergoing robotic-assisted radical prostatectomy for non-metastatic prostate cancer? A propensity score matched analysis
Eragamreddy SK, Damirova F, Roome H, Soteriou I, Patel M, Gopalakrishnan A, Islam A, Ahmed A, Tan T, Bertoncelli Tanaka M, Khoubehi B, Hellawell G, Shah T, Heer R, Ahmed HU, Winkler M, Connor MJ.
J Urol · 2026; 215(5S)
A prospective, paired-cohort, blinded, validation of the IBEX prostate AI pathology system compared to expert uro-pathology reporting of prostate biopsies: the cancer histology artificial intelligence reliability study (IP6-CHAIROS)
Ahmed HU, Sukumar J, Markham H, Al-Sam SZ, Lloyd J, Smith A, Silvanto A, Snead D, Tilley C, Magdy N, Prasad C, Gopinath P, Freeman A, Cullen E, Rawlins F, Dalton R, Thiagarajah S, Klimowska-Nassar NM, Winkler M, Lin C, Davies D, Mckee S, Hewitt D, Kansara A, Szajna M, Khoubehi B, Costa P, et al.
J Urol · 2026; 215(5S)
Professional Approach
Mr Khoubehi takes a meticulous, patient-focused approach to urological care. He believes that every individual deserves a thorough evaluation and a clear, honest discussion of all available treatment options — from active surveillance through to the most advanced surgical interventions.
Private Clinic Locations
Mr Khoubehi holds private outpatient clinics at two central London locations.
Chelsea Outpatient Centre
Chelsea, London
18 Devonshire Street
Marylebone, London
Weekly Schedule
Monday
Chelsea Outpatient Centre
Wednesday
18 Devonshire Street
Thursday
Chelsea Outpatient Centre
Friday
18 Devonshire Street
What Mr Khoubehi's Patients Say
Choosing the right specialist is a big decision. Hear directly from the patients who have trusted Mr Khoubehi with their care — every review independently verified by Doctify.
His extensive experience as a high-volume robotic surgeon, combined with world-class results for cancer margins, continence and potency, gives patients confidence that they are in the hands of one of the UK's leading urological surgeons.
Ready to Take the Next Step?
Whether you need a specialist opinion, a second consultation, or wish to discuss treatment options, Mr Khoubehi and the London Urology Specialists team are here to help.